Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II Trial

NCT07731828 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Cervical Neoplasms

Interventions

DRUG: Adebrelimab

Sponsor

The First Affiliated Hospital with Nanjing Medical University